NWBO - Northwest Biotherapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5124.68M
Enterprise Value 3131.46M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)201.43
Price/Book (mrq)N/A
Enterprise Value/Revenue 3212.38
Enterprise Value/EBITDA 6-3.07

Trading Information

Stock Price History

Beta (3Y Monthly) 1.95
52-Week Change 37.73%
S&P500 52-Week Change 36.52%
52 Week High 30.3500
52 Week Low 30.1800
50-Day Moving Average 30.2680
200-Day Moving Average 30.2765

Share Statistics

Avg Vol (3 month) 31.13M
Avg Vol (10 day) 31.49M
Shares Outstanding 5544.47M
Float 501.34M
% Held by Insiders 19.75%
% Held by Institutions 19.72%
Shares Short (Nov 30, 2016) 414.14M
Short Ratio (Nov 30, 2016) 413.54
Short % of Float (Nov 30, 2016) 415.09%
Short % of Shares Outstanding (Nov 30, 2016) 411.34%
Shares Short (prior month Oct 31, 2016) 413.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 216/1
Last Split Date 3Sep 26, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-7,060.90%

Management Effectiveness

Return on Assets (ttm)-73.58%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)619k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)156.80%
Gross Profit (ttm)-17.74M
EBITDA -42.78M
Net Income Avi to Common (ttm)-42.9M
Diluted EPS (ttm)-0.0890
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.29M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)23.07M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.25
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)-39.55M
Levered Free Cash Flow (ttm)-35.05M